1. Home
  2. GH vs MNSO Comparison

GH vs MNSO Comparison

Compare GH & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.92

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo MINISO Group Holding Limited

MNSO

MINISO Group Holding Limited

HOLD

Current Price

$19.51

Market Cap

5.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
MNSO
Founded
2011
2013
Country
United States
China
Employees
N/A
N/A
Industry
Medical Specialities
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
5.8B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
GH
MNSO
Price
$101.92
$19.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
2
Target Price
$82.76
$24.10
AVG Volume (30 Days)
2.2M
681.0K
Earning Date
10-29-2025
11-20-2025
Dividend Yield
N/A
3.35%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$902,569,000.00
$2,795,603,723.00
Revenue This Year
$34.72
$27.64
Revenue Next Year
$26.46
$19.31
P/E Ratio
N/A
$19.99
Revenue Growth
30.38
23.44
52 Week Low
$29.91
$13.95
52 Week High
$112.43
$27.71

Technical Indicators

Market Signals
Indicator
GH
MNSO
Relative Strength Index (RSI) 55.40 39.93
Support Level $100.21 $19.29
Resistance Level $109.59 $19.76
Average True Range (ATR) 4.22 0.38
MACD -1.65 0.06
Stochastic Oscillator 13.51 52.16

Price Performance

Historical Comparison
GH
MNSO

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: